Reis Janice Sepúlveda, Lamounier Rodrigo Nunes, Menezes Patrícia A F C, Calsolari Maria R, Purisch Saulo
Serviço de Endocrinologia e Metabologia, Santa Casa de Belo Horizonte, MG, Brasil.
Arq Bras Endocrinol Metabol. 2008 Jun;52(4):697-700. doi: 10.1590/s0004-27302008000400017.
The type 1 diabetic patient pregnancy is subjected to various attempts to obtain good glycemic control, since the pre-conception period throughout the gestation. Continuous subcutaneous insulin infusion (CSII) is a therapeutic tool to achieve the glycemic targets. Here it is presented the case of a Type 1 diabetic woman, who was not under multiple insulin daily injections therapy, and whose insulin therapy started on CSII during the second trimester of gestation, obtaining successful therapeutic outcome.
1型糖尿病患者怀孕后，从孕前到整个孕期都需要进行各种尝试以实现良好的血糖控制。持续皮下胰岛素输注（CSII）是实现血糖目标的一种治疗手段。本文介绍了一名1型糖尿病女性的病例，她未接受每日多次胰岛素注射治疗，在妊娠中期开始采用CSII进行胰岛素治疗，并获得了成功的治疗效果。
